share_log

CNS Pharmaceuticals | SC 13D: Statement of acquisition of beneficial ownership by individuals-Cortice Biosciences, Inc.(5.7%)

SEC ·  Aug 2 15:16
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more